{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T14:17:29Z","timestamp":1777990649877,"version":"3.51.4"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:title>EXECUTIVE SUMMARY<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Delirium is associated with increased intensive care unit and hospital length of stay, prolonged duration of mechanical ventilation, unplanned removal of tubes and catheters, and increased morbidity and mortality. Prophylactic treatment with low-dose haloperidol may have beneficial effects for critically ill patients with a high risk of delirium.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>To identify the effectiveness of haloperidol prophylaxis in critically ill patients with a high risk for delirium.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Inclusion criteria Types of participants<\/jats:title>\n            <jats:p>Patients with a predicted high risk of delirium, aged 18 years or over, and in intensive care units. Patients with a history of concurrent antipsychotic medication use were excluded.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Types of intervention(s)\/phenomena of interest<\/jats:title>\n            <jats:p>Haloperidol prophylaxis for preventing delirium.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Types of studies<\/jats:title>\n            <jats:p>Experimental and epidemiological study designs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes<\/jats:title>\n            <jats:p>Primary outcome is the incidence of delirium. Secondary outcomes are duration of mechanical ventilation, incidence of re-intubation, incidence of unplanned\/accidental removal of tubes\/lines and catheters, intensive care unit and hospital length of stay, and re-admissions to both settings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Search strategy<\/jats:title>\n            <jats:p>An initial search of MEDLINE and CINAHL was undertaken, followed by a second search for published and unpublished studies from January 1967 to September 2015 in major healthcare-related electronic databases. Studies in English, Spanish and Portuguese were included.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methodological quality<\/jats:title>\n            <jats:p>Two independent reviewers assessed the methodological quality of five studies using the standardized critical appraisal instrument from the Joanna Briggs Institute Meta-Analysis of Statistics Assessment and Review Instrument. There was general agreement among the reviewers to exclude one relevant study due to methodological quality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Data extraction<\/jats:title>\n            <jats:p>Data were extracted using the JBI data extraction form for experimental studies and included details about the interventions, populations, study methods and outcomes of significance to the review questions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Data synthesis<\/jats:title>\n            <jats:p>Significant differences were found between participants, interventions, outcome measures (clinical heterogeneity) and designs (methodological heterogeneity). For these reasons, we were unable to perform a meta-analysis. Therefore, the results have been described in a narrative format.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Five studies met the inclusion criteria. One of these studies was excluded due to poor methodological quality. The remaining four original studies (total of 1142 patients) were included in this review. Three studies were randomized controlled trials and one was a cohort study.<\/jats:p>\n            <jats:p>Two studies confirmed the effectiveness of haloperidol prophylaxis in critically ill patients with a high risk of delirium. These studies showed that short-term prophylactic administration of low-dose intravenous haloperidol significantly decreased the incidence of delirium in elderly patients admitted to intensive care units after non-cardiac surgery and in general intensive care unit patients with a high risk of delirium.<\/jats:p>\n            <jats:p>However, the two remaining studies showed contradictory results in mechanically ventilated critically ill adults, revealing that the administration of haloperidol reduced delirium prevalence, delayed its occurrence, and\/or shorten its duration.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The evidence related to the effectiveness of haloperidol prophylaxis in critically ill patients with a high risk of delirium is contradictory. However, balancing the benefits and low side effects associated with haloperidol prophylaxis, this preventive intervention may be useful to reduce the incidence of delirium in critically ill adults in intensive care units.<\/jats:p>\n          <\/jats:sec>","DOI":"10.11124\/jbisrir-2017-003391","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T16:23:28Z","timestamp":1494519808000},"page":"1440-1472","source":"Crossref","is-referenced-by-count":23,"title":["Effectiveness of haloperidol prophylaxis in critically ill patients with a high risk of delirium: a systematic review"],"prefix":"10.11124","volume":"15","author":[{"given":"Eduardo","family":"Santos","sequence":"first","affiliation":[{"name":"Health Sciences Research Unit: Nursing, Nursing School of Coimbra, Portugal Centre for Evidence Based Practice: a Joanna Briggs Institute Centre of Excellence"},{"name":"Emergency Department: Centro Hospitalar e Universit\u00e1rio de Coimbra (CHUC), Coimbra, Portugal"}]},{"given":"Daniela","family":"Cardoso","sequence":"additional","affiliation":[{"name":"Health Sciences Research Unit: Nursing, Nursing School of Coimbra, Portugal Centre for Evidence Based Practice: a Joanna Briggs Institute Centre of Excellence"}]},{"given":"Hugo","family":"Neves","sequence":"additional","affiliation":[{"name":"Health Sciences Research Unit: Nursing, Nursing School of Coimbra, Portugal Centre for Evidence Based Practice: a Joanna Briggs Institute Centre of Excellence"}]},{"given":"Madalena","family":"Cunha","sequence":"additional","affiliation":[{"name":"Research and Development Unit, Centre of Studies in Education, Health and Technology, Viseu,Portugal"}]},{"given":"Manuel","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Health Sciences Research Unit: Nursing, Nursing School of Coimbra, Portugal Centre for Evidence Based Practice: a Joanna Briggs Institute Centre of Excellence"}]},{"given":"Jo\u00e3o","family":"Ap\u00f3stolo","sequence":"additional","affiliation":[{"name":"Health Sciences Research Unit: Nursing, Nursing School of Coimbra, Portugal Centre for Evidence Based Practice: a Joanna Briggs Institute Centre of Excellence"}]}],"member":"276","reference":[{"issue":"2","key":"R1-20230825","first-page":"CD005563","article-title":"Interventions for preventing delirium in hospitalised patients","author":"Siddiqi","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"R2-20230825","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nrneurol.2009.24","article-title":"Delirium in elderly adults: diagnosis, prevention and treatment","volume":"5","author":"Fong","year":"2009","journal-title":"Nat Rev Neurol"},{"key":"R3-20230825","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(10)61855-7","article-title":"Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial","volume":"376","author":"van Eijk","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"R4-20230825","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/CCM.0b013e3181c58715","article-title":"Feasibility, Efficacy, and Safety of Antipsychotics for ICU Delirium: the MIND Randomized, Placebo-Controlled Trial","volume":"38","author":"Girard","year":"2010","journal-title":"Crit Care Med"},{"issue":"(R84)","key":"R5-20230825","first-page":"1","article-title":"Antipsychotic use and diagnosis of delirium in the intensive care unit","volume":"16","author":"Swan","year":"2012","journal-title":"Crit Care"},{"issue":"4","key":"R6-20230825","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/icvts\/ivt501","article-title":"Effects of a screening and treatment protocol with haloperidol on post-cardiotomy delirium: a prospective cohort study","volume":"18","author":"Schroder Pedersen","year":"2014","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"7","key":"R7-20230825","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S2213-2600(13)70166-8","article-title":"Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial","volume":"1","author":"Page","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"10","key":"R8-20230825","first-page":"25","article-title":"Insight into Delirium","volume":"8","author":"Ali","year":"2011","journal-title":"Innov Clin Neurosci"},{"issue":"3","key":"R9-20230825","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1186\/cc7890","article-title":"Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial","volume":"13","author":"Reade","year":"2009","journal-title":"Crit Care"},{"issue":"3","key":"R10-20230825","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.psym.2011.12.005","article-title":"A review of pharmacologic management and prevention strategies for delirium in the intensive care unit","volume":"53","author":"Bledowski","year":"2012","journal-title":"Psychosomatics"},{"issue":"1","key":"R11-20230825","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1186\/cc11933","article-title":"Haloperidol prophylaxis in critically ill patients with a high risk for delirium","volume":"17","author":"Boogaard","year":"2013","journal-title":"Crit Care"},{"issue":"1","key":"R12-20230825","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00003246-200201000-00020","article-title":"Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult","volume":"30","author":"Jacobi","year":"2002","journal-title":"Crit Care Med"},{"issue":"3","key":"R13-20230825","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/CCM.0b013e3182376e4f","article-title":"Haloperidol prophylaxis decreases delirium incidence in elderly patients after noncardiac surgery: a randomized controlled trial","volume":"40","author":"Wang","year":"2012","journal-title":"Crit Care Med"},{"key":"R14-20230825","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/2110-5820-2-49","article-title":"Delirium in the ICU: an overview","volume":"2","author":"Cavallazzi","year":"2012","journal-title":"Ann Intensive Care"},{"issue":"7","key":"R16-20230825","doi-asserted-by":"crossref","first-page":"83","DOI":"10.11124\/01938924-201513070-00008","article-title":"Effectiveness of haloperidol prophylaxis in critically ill patients with a high risk for delirium: a systematic review of quantitative evidence protocol","volume":"13","author":"Santos","year":"2015","journal-title":"JBI Database System Rev Implement Rep"},{"issue":"3","key":"R17-20230825","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/XEB.0000000000000065","article-title":"Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness","volume":"13","author":"Tufanaru","year":"2015","journal-title":"International Journal of Evidence-Based Healthcare"},{"issue":"3","key":"R18-20230825","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/CCM.0000000000001411","article-title":"Preventing ICU Subsyndromal Delirium Conversion to Delirium With Low-Dose IV Haloperidol: A Double-Blind, Placebo-Controlled Pilot Study","volume":"44","author":"Al-Qadheeb","year":"2016","journal-title":"Crit Care Med"},{"issue":"1","key":"R19-20230825","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/MCC.0b013e3283427243","article-title":"Sedation, delirium and mechanical ventilation: the \u2018ABCDE\u2019 approach","volume":"17","author":"Morandi","year":"2011","journal-title":"Current opinion in critical care"},{"issue":"22","key":"R20-20230825","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1001\/jama.298.22.2644","article-title":"Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial","volume":"298","author":"Pandharipande","year":"2007","journal-title":"Jama"},{"issue":"2","key":"R21-20230825","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/CCM.0b013e3181b9e302","article-title":"Efficacy and safety of quetiapine in critically ill patients with delirium: A prospective, multicenter, randomized, double-blind, placebo-controlled pilot study\u2217","volume":"38","author":"Devlin","year":"2010","journal-title":"Crit Care Med"},{"issue":"5","key":"R22-20230825","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/ALN.0b013e31825153cc","article-title":"Early treatment with risperidone for subsyndromal delirium after on-pump cardiac surgery in the elderly: a randomized trial","volume":"116","author":"Hakim","year":"2012","journal-title":"Anesthesiology"},{"issue":"1","key":"R23-20230825","first-page":"1","article-title":"Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial","volume":"15","author":"Van Eijk","year":"2011","journal-title":"Crit Care"},{"issue":"3","key":"R24-20230825","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00134-003-2117-0","article-title":"Olanzapine vs haloperidol: treating delirium in a critical care setting","volume":"30","author":"Skrobik","year":"2004","journal-title":"Intensive Care Med"}],"container-title":["JBI Database of Systematic Reviews and Implementation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01938924-201705000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T05:11:41Z","timestamp":1692940301000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01938924-201705000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.11124\/jbisrir-2017-003391","relation":{},"ISSN":["2202-4433"],"issn-type":[{"value":"2202-4433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}